Zymeworks Inc. Common Stock Cash Flow-to-Debt Ratio
Zymeworks Inc. Common Stock cash flow-to-debt ratio. Zymeworks Inc. Common Stock (ZYME) has a Cash Flow-to-Debt Ratio of -0.41x as of September 2025, meaning its operating cash flow of $-31.41 Million could theoretically repay 0% of its total liabilities ($77.20 Million) in one year. Check Zymeworks Inc. Common Stock cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zymeworks Inc. Common Stock (2014–2024)
Cash flow-to-debt ratio of Zymeworks Inc. Common Stock from 2014 to 2024. Historical debt coverage capacity for Zymeworks Inc. Common Stock across 11 annual periods. Check ZYME cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zymeworks Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2014–2024)
Zymeworks Inc. Common Stock cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Zymeworks Inc. Common Stock. For the full cash flow conversion analysis, see ZYME cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.89x | $-110.04 Million | $124.32 Million | ▲ +13.2% |
| 2023 | -1.02x | $-118.30 Million | $116.07 Million | ▼ -210.2% |
| 2022 | 0.93x | $144.11 Million | $155.77 Million | ▲ +167.3% |
| 2021 | -1.37x | $-192.45 Million | $140.04 Million | ▼ -16.6% |
| 2020 | -1.18x | $-151.40 Million | $128.45 Million | ▼ -76.4% |
| 2019 | -0.67x | $-81.85 Million | $122.52 Million | ▼ -276.5% |
| 2018 | 0.38x | $24.18 Million | $63.87 Million | ▲ +2583.7% |
| 2017 | 0.01x | $219.00K | $15.53 Million | ▲ +103.4% |
| 2016 | -0.41x | $-35.25 Million | $84.99 Million | ▲ +90.8% |
| 2015 | -4.52x | $-22.17 Million | $4.91 Million | ▼ -601.8% |
| 2014 | -0.64x | $-7.02 Million | $10.90 Million | — |